Skip to main content

Merck & Company Inc (MRK) Stock

Merck & Company Inc Stock Details, Movements and Public Alerts

Stock Details

Merck & Company Inc (MRK), a prominent company in the healthcare sector within the drug manufacturers - general industry, is based in USA and primarily trades on the NYSE.Currently, the stock is trading at $100.33. Over the past 52 weeks, it has ranged between $71.87 and $105.84. This places the current price at 94.8% of its 52-week high and 39.6% above its 52-week low. Recent trading volume was recorded at 11,774,677. The 14-day Relative Strength Index (RSI) stands at 57.11, suggesting neutral conditions. The stock is currently trading above its 50-day moving average of $91.54 by 9.60%. Similarly, it is above its 200-day moving average of $84.06 by 19.36%. The MACD histogram is -0.80, indicating bearish momentum (MACD Line: 2.42, Signal Line: 3.22). The International Securities Identification Number (ISIN) for this stock is US58933Y1055. There is currently 1 active alert set for MRK by users.

52-Week Range

$105.84 - $71.87

-5.21% from high · +39.60% from low

Avg Daily Volume

16,162,115

20-day average

100-day avg: 12,848,644

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

13.87

Below market average

Forward P/E

11.15

Earnings expected to grow

PEG Ratio

1.10

Reasonably valued

Price to Book

5.02

EV/EBITDA

10.24

EPS (TTM)

$7.56

Price to Sales

4.08

Beta

0.32

Less volatile than market

How is MRK valued relative to its earnings and growth?
Merck & Company Inc trades at a P/E ratio of 13.87, which is below the market average of approximately 20. This lower valuation could indicate the market has modest growth expectations, or it might represent an undervalued opportunity if the fundamentals are strong. Looking ahead, the forward P/E of 11.15 is lower than the current P/E, indicating analysts expect earnings to grow over the next year. The PEG ratio of 1.10 indicates reasonable value when growth is considered.
What is MRK's risk profile compared to the market?
With a beta of 0.32, Merck & Company Inc is less volatile than the overall market. This means when the market moves up or down by 10%, this stock typically moves less than 10% in the same direction. Lower beta stocks are often preferred by conservative investors seeking stability. The price-to-book ratio of 5.02 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

29.60%

Operating Margin

40.80%

EBITDA

$31.52B

Return on Equity

39.50%

Return on Assets

13.80%

Revenue Growth (YoY)

3.70%

Earnings Growth (YoY)

87.00%

How profitable and efficient is MRK's business model?
Merck & Company Inc achieves a profit margin of 29.60%, meaning it retains $29.60 from every $100 in revenue after all expenses. This is an impressive margin, indicating strong pricing power and efficient cost management that allows the company to generate substantial profits. The operating margin of 40.80% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at 39.50% and ROA at 13.80%, the company generates strong returns on invested capital.
What are MRK's recent growth trends?
Merck & Company Inc's revenue grew by 3.70% year-over-year, showing steady progress in growing the business. This positive trajectory indicates the company maintains competitive positioning in its markets. Earnings increased by 87.00% year-over-year, outpacing revenue growth through improved margins. These growth metrics should be evaluated against DRUG MANUFACTURERS - GENERAL industry averages for proper context.

Dividend Information

Dividend Per Share

$3.20

Dividend Yield

3.06%

Ex-Dividend Date

Dec 15, 2025

Dividend Date

Jan 8, 2026

What dividend income can investors expect from MRK?
Merck & Company Inc offers a dividend yield of 3.06%, paying $3.20 per share annually. This above-average yield of 2-4% provides meaningful income while still allowing the company to reinvest for growth. It compares favorably to the S&P 500 average and offers competitive returns versus bonds in the current rate environment. To receive the next dividend, shares must be purchased before the ex-dividend date of Dec 15, 2025.
How reliable is MRK's dividend for long-term investors?
The dividend sustainability can be assessed through the payout ratio - Merck & Company Inc pays $3.20 per share in dividends against earnings of $7.56 per share, resulting in a payout ratio of 42.33%. This balanced payout between 30-60% suggests a sustainable dividend policy that allows both shareholder returns and business reinvestment. The dividend appears well-covered by earnings. The next dividend payment is scheduled for Jan 8, 2026.

Company Size & Market

Market Cap

$261.8B

Revenue (TTM)

$64.23B

Revenue/Share (TTM)

$25.56

Shares Outstanding

2.48B

Book Value/Share

$20.84

Asset Type

Common Stock

What is MRK's market capitalization and position?
Merck & Company Inc has a market capitalization of $261.8B, classifying it as a mega-cap stock (over $200B). These are the largest, most established companies globally, typically offering stability and liquidity but with more modest growth potential. Mega-caps often pay dividends and weather economic downturns better than smaller companies. With 2.48B shares outstanding, the company's ownership is widely distributed. As a major player in the DRUG MANUFACTURERS - GENERAL industry, it competes with other firms in this sector.
How does MRK's price compare to its book value?
Merck & Company Inc's book value per share is $20.84, while the current stock price is $100.33, resulting in a price-to-book (P/B) ratio of 4.81. This high P/B ratio indicates significant intangible assets, strong brand value, or high growth expectations. Technology and consumer brand companies often trade at elevated P/B ratios due to intellectual property and competitive advantages not reflected on the balance sheet. As a common stock, this represents equity ownership with voting rights.

Analyst Ratings

Analyst Target Price

$104.27

3.93% upside potential

Analyst Recommendations

Strong Buy

2

Buy

12

Hold

13

Sell

0

Strong Sell

0

How reliable are analyst predictions for MRK?
27 analysts cover MRK with 52% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The mixed views reflect uncertainty about the outlook. The consensus target of $104.27 implies 3.9% upside, but targets are often adjusted to follow price moves rather than predict them.
What is the Wall Street consensus on MRK?
Current analyst recommendations:2 Strong Buy, 12 Buy, 13 Hold, 00The bullish tilt suggests optimism about future prospects, though investors should conduct independent research.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Dec 1, 2025, 02:25 AM

Technical Indicators

RSI (14-day)

57.11

Neutral

50-Day Moving Average

$91.54

9.60% above MA-50

200-Day Moving Average

$84.06

19.36% above MA-200

MACD Line

2.42

MACD Signal

3.22

MACD Histogram

-0.80

Bearish

What does MRK's RSI value tell investors?
The RSI (Relative Strength Index) for MRK is currently 57.11, indicating the stock is in neutral territory (40-60 range). Neither buyers nor sellers have clear control, suggesting consolidation or balanced market forces. Combined with the price being above the 50-day moving average, this confirms bullish conditions.
How should traders interpret MRK's MACD and moving average crossovers?
MACD analysis shows the MACD line at 2.42 below the signal line at 3.22, with histogram at -0.80. This bearish crossover indicates downward pressure. The 50-day MA ($91.54) is above the 200-day MA ($84.06), forming a golden cross pattern that typically signals a long-term uptrend. Price is currently above both MAs, confirming strength.

Indicators last updated: Dec 12, 2025, 12:51 AM

Active Alerts

Alert Condition
P/E Ratio falls below
Threshold
11 x
Created
Dec 3, 2025, 09:36 PM

Stay Ahead of the Market with Merck & Company Inc Alerts

Set up price alerts for Merck & Company Inc and get notified instantly when the price hits your target. Never miss an important price movement again.